Myocardial Infarction Treatment Market by Product type (Antiplatelet agents, Glycoprotein IIb/IIIa inhibitors, Antithrombotic agents, Beta-adrenergic blockers, Vasodilators, Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin-Receptor blockers, Analgesics, Thrombolytics); Distribution channel (Hospitals, Hospital Pharmacies, Drug Stores and Online Drug Stores); and Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global Myocardial Infarction Treatment Market expected to reach USD 1726.3 million by end of 2022, growing at a CAGR of 6.1% between 2017 and 2022.

14-Feb-2017 | Number of pages: 110 | Report Code: ZMR-1084 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the myocardial infarction treatment market on a global and regional level. The study provides historic data from 2014 along with a forecast for 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the myocardial infarction treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the myocardial infarction treatment market on a global level.

In order to give the users of this report a comprehensive view on the myocardial infarction treatment market, we have to include competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type and distribution channel segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new Therapy launch, agreements, partnerships, collaborations & joint ventures, research& development, Therapy and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, Therapy portfolio of various companies along with patent analysis (2011-2016) bifurcated into a patent trend, patent share by company and patent analysis according to the region.

The study provides a decisive view on the myocardial infarction treatment market by segmenting the market based on product type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on product type the market is segmented into antiplatelet agents, glycoprotein IIb/IIIa inhibitors, antithrombotic agents, beta-adrenergic blockers, vasodilators, angiotensin-converting enzyme (ace) inhibitors, angiotensin-receptor blockers, analgesics, thrombolytics. Key distribution channels covered under this study includes hospitals, hospital pharmacies, drug stores and online drug stores. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for myocardial infarction treatment based on individual product type and distribution channel in all the regions and countries.

The report also includes detailed profiles of end players such as Bayer, Novartis, Daiichi Sankyo Company Limited, Boehringer Ingelheim GmbH, Sandoz, Astrazeneca, Janssen Biotech, Inc., Merck & Co. Inc., Sanofi, Pfizer Inc. among others.

This report segments the global myocardial infarction treatment market as follows:

Myocardial Infarction Treatment Market: By Product Type

  • Antiplatelet agents
  • Glycoprotein IIb/IIIa inhibitors
  • Antithrombotic agents
  • Beta-adrenergic blockers
  • Vasodilators
  • Angiotensin-Converting Enzyme (ACE) inhibitors
  • Angiotensin-Receptor blockers
  • Analgesics
  • Thrombolytics

Myocardial Infarction Treatment Market: By Distribution Channel

  • Hospitals
  • Hospital Pharmacies
  • Drug Stores
  • Online Drug Stores

Global Myocardial Infarction Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany 
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Infection Control Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1571 | Report Format:

Global Infection Control Market: Overview Microorganisms such as fungi, bacteria, and virus are main sources of infections. Various kind of infections are eye infections, hospital acquired infections, skin infections, common childhood infections, ear infections, sexually transmitted infections, ...Read More

Pharmaceutical Filtration Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1565 | Report Format:

Global Pharmaceutical Filtration Market: Overview During the manufacturing process of small molecule drugs, the filters are utilized in several stages which are also acknowledged as active pharmaceutical ingredients (APIs). They help in removing or minimizing the bacteria and particles in the pr...Read More

Medical Composites Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1563 | Report Format:

Global Medical Composites Market: Overview Large scale components are included in the medical composites that range from those used in X-ray applications to the composite bolts that are used to internally underpin the bones. They are used in equipment components which include mammogram plates to...Read More

Downstream Processing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1561 | Report Format:

Global Downstream Processing Market: Overview Downstream processing is a process wherein purification is done and the biosynthetic products are recovered especially the pharmaceuticals that are obtained from the natural sources. The downstream processing includes five stages that are solid-liqui...Read More

Nocturia Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1528 | Report Format:

Global Nocturia Market: Overview Experiencing frequent urge of urination during the night after sleeping is a medical condition that is termed as nocturia or nocturnal polyuria. This happens among the aged patients and sleep deficiency can often lead to nocturia. The women that are between 18 to...Read More

Choose License Type:
Latest Published Reports

View All Published Reports